Gautam Patel, Director at Amneal Pharmaceuticals, Inc. (AMRX), sold 112,852 shares at $8.02 ($905K) on 2025-06-10, disclosed to the SEC on 2025-06-12.
Open-market sale of $905k AMRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.02 | 56,426 | $453K | 50.0% |
| 2 | $8.02 | 56,426 | $453K | 50.0% |
| Total | $8.02 avg | 112,852 | $905K | 100% |
| Filing → |
| AMRX | SELL | 2025-04-02 | $664K | — | Filing → |
| AMRX | SELL | 2025-03-05 | $712K | — | Filing → |
| AMRX | SELL | 2025-02-05 | $651K | — | Filing → |